发明申请
US20060153861A1 BCR-ABL imatinib resistance-associated peptides and methods of use thereof
审中-公开
BCR-ABL伊马替尼耐药相关肽及其使用方法
- 专利标题： BCR-ABL imatinib resistance-associated peptides and methods of use thereof
- 专利标题（中）： BCR-ABL伊马替尼耐药相关肽及其使用方法
-
申请号： US11237939申请日： 2005-09-29
-
公开(公告)号： US20060153861A1公开(公告)日： 2006-07-13
- 发明人: David Scheinberg , Javier Pinilla-Ibarz
- 申请人： David Scheinberg , Javier Pinilla-Ibarz
- 主分类号： A61K39/00
- IPC分类号： A61K39/00 ; A61K38/20 ; A61K38/19 ; A61K38/10 ; A61K38/08 ; C07K14/82 ; C07K7/08
摘要：
The present invention is directed to immunogenic peptides, compositions and vaccines comprising same, and methods of use thereof for treating, inhibiting or reducing the incidence of a cancer associated with an activated kinase, and methods of generating a heteroclitic immune response against, or cytotoxic T cells specifically recognizing cancer cells which are associated with an activated kinase.
信息查询
